Parkinson's Disease: A Progressive Nervous System Disorder By: Falak Surahio
Parkinson's disease (PD) is a neurological condition that causes problems with movement and worsens
over time. It weakens, damages, and kills nerve cells in some areas of the brain. Parkinson’s disease is
important because it is a chronic and incurable neurological disorder that affects millions of people
around the world. It kills dopamine producing brain cells, which significantly affects physical mobility,
intellectual skills, and mental health. It is also an important model for medical research to understand
aging and neurodegeneration.
Whose affected by it?
Parkinson disease could be more likely to develop if you:
- Are over 60: Although a less common early development type can start before the age 50, symptoms
often start around the age of 60.
- Are male: Even though Parkinson's disease can impact anyone, men are more likely to be diagnosed
with it.
- Genetics: If you have a close biological relative who suffers from Parkinson disease, you are more likely
to develop it.
- Exposure to certain toxins: Risk of Parkinson may be increased by pesticide contact or continuous
exposure to metals like manganese, which are frequently found in welding.
Causes
Most symptoms of Parkinson’s Disease (PD) are as a result of the weakening, damage and death of
cells in the brain’s substantia nigra. These cells produce dopamine, a key chemical messenger that
allows us to perform normal and intentional movements. By the time signs of Parkinson's disease
appear, people have usually lost 60 to 80% or more of these dopamine-producing neurones (nerve
cells). Also, people with PD have damaged brain cells that produce norepinephrine. Norepinephrine is
important for involuntary bodily functions such as controlling blood pressure and heart rate . The loss
of this compound is associated with symptoms not related to movement such as fatigue and blood
pressure changes . Most PD patients also have Lewy bodies in damaged brain cells, which are abnormal
clumps of the protein alpha-synuclein, but the exact cause and effect of these structures is still unclear.
Symptoms
Parkinson can result in a number of symptoms:
- Issues with balance and mobility
- Tremors, or uncontrollably shaking hands or fingers
- Stiffness
People with Parkinson's disease (PD) can also experience difficulties when walking, speaking, or
performing everyday tasks when their symptoms worsen.
Diagnosis
As of today, Parkinson's disease cannot be diagnosed using a specific test. Based on symptoms,
medical history, and neurological and physical examinations, a neurologist makes the diagnosis. In
order to determine the condition and symptoms throughout time, the diagnosis process may take a
long time.
Treatments
While there's not a current cure for Parkinson's disease, medications can help manage its
symptoms. Most of the time the medications are effective. Some patients may undergo surgery though
when the medication is no longer effective.
Common medications include:
Carbidopa-levodopa: Most of the time this is the most effective medication, however it may cause
dyskinesia and nausea.
Dopamine agonists: Such as apomorphine and pramipexole, which mimic the effects of dopamine.
MAO B inhibitors: This medication prevents dopamine from being broken down but confusion is one
of the negative effects of it
COMT inhibitors: Prolong the effects of levodopa but may cause nausea and diarrhoea.
Anticholinergics: Used to treat tremors but it may cause memory loss and urinary problems are side
effects.
Amantadine: Helps with involuntary movements but may cause hallucinations are one of the possible
side effects of amantadine.
Surgical options:
Deep Brain Stimulation (DBS): An effective treatment for severe tremors and dyskinesia but it has
possible side effects like infection and speech issues.
MRI-guided focused ultrasound: Is a newer, less invasive method for treating tremors.
Patient impact
Parkinson's disease has significant effects on the physical, emotional, mental, and social wellbeing
of patients. As the disease worsens, it makes it harder to move and do daily tasks. It becomes more
difficult to do things like walking, dressing, cooking, shopping and personal hygiene. Muscle stiffness,
balance issues, fatigue, painful cramps and increased risk of falls are experienced as well by many
patients. Mental shifts such as memory loss, poor concentration and difficulty communicating can
decrease independence. As patients become more emotionally dependent on others, they may feel
anxiety, depression, fear for the future and loss of confidence. On a social level, speech problems,
limited mobility and embarrassment about symptoms can lead to isolation. Many patients cope by
planning carefully, using mobility aids, taking medication on time and relying on support from family
and healthcare professionals.
Statistics.
- Nearly an estimated 90,000 people in the U.S. are diagnosed with PD each year. (Parkinson
Foundation)
- Young-onset Parkinson’s disease (YOPD) occurs in people under 50 and shares many
symptoms with typical PD. (Parkinson Foundation)
- People with young onset Parkinson's disease often experience slower symptom progression,
fewer cognitive issues and more medication-related side effects like dyskinesias and dystonias.
(Parkinson Foundation)
- More than 10 million people worldwide are estimated to be living with PD. (Parkinson
Foundation)
- The incidence of parkinson increases with age, but an estimated 4% of people with PD are
diagnosed before age 50. (Parkinson Foundation)
- Men are 1.5 times more likely to have Parkinson's disease than women. (Parkinson
Foundation)
- An estimated 1.1 million people in the U.S. are living with Parkinson's disease (PD). This
number is expected to rise to 1.2 million by 2030. Parkinson's is the second-most common
neurodegenerative disease after Alzheimer's disease. (Parkinson Foundation)
Why does this matter?
Parkinson's disease is currently the neurological disorder with the largest global growth rate, but it is
often misunderstood. By raising awareness, we can fund innovative research, fight for improved care,
and challenge established beliefs. By working together, we can build a future where people with
Parkinson's disease and their carers have the resources, encouragement, and optimism they require to
succeed.
Sources:
National Institute of Neurological Disorders and Stroke. “Parkinson’s Disease.” National Institute of
Neurological Disorders and Stroke, National Institute of Neurological Disorders and Stroke, 5 Mar.
2025, https://www.ninds.nih.gov/health-information/disorders/parkinsons-disease. Accessed 6 July
2026.
Cleveland Clinic. “Parkinson’s Disease: Causes, Symptoms, Stages, Treatment, Support.” Cleveland
Clinic, 15 Apr. 2022,
https://my.clevelandclinic.org/health/diseases/8525-parkinsons-disease-an-overview. Accessed 6 July
2026.
Mayo Clinic. (2023). Parkinson’s disease - Diagnosis and treatment. Mayoclinic.Org.
https://www.mayoclinic.org/diseases-conditions/parkinsons-disease/diagnosis-treatment/drc-2037606
2
Sjödahl Hammarlund, Catharina, et al. “The Impact of Living with Parkinson’s Disease: Balancing
within a Web of Needs and Demands.” Parkinson’s Disease, vol. 2018, no. 4598651, July 2018, pp.
1–8, https://doi.org/10.1155/2018/4598651.
Parkinson’s Foundation. “Statistics.” Parkinson’s Foundation, 2025,
https://www.parkinson.org/Understanding-Parkinsons/Statistics. Accessed 6 July 2026.
“Parkinson’s Awareness Month - Parkinson Canada.” Parkinson Canada -, 17 Mar. 2025,
Comments
Post a Comment